Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial cell membranes and cell wall envelope lipids are fundamental structural and functional barriers that protect bacteria and fungi from their environment while maintaining internal homeostasis. In bacteria, the cytoplasmic membrane is primarily composed of phospholipids like phosphatidylglycerol, while the cell envelope of Gram-negative bacteria contains lipopolysaccharides, and Mycobacteria possess a unique waxy layer of mycolic acids (Nataraj et al., 2015, Chemical Reviews). Fungal membranes are distinguished by the presence of ergosterol, which serves a similar stabilizing role to cholesterol in animal cells but provides a specific target for antifungal agents (Mesa-Arango et al., 2012, Frontiers in Microbiology). These lipid components are essential for processes such as nutrient transport, energy transduction, and the anchoring of cell wall biosynthetic machinery. As therapeutic targets, these lipids are highly effective because their disruption often leads to rapid, bactericidal or fungicidal activity. For instance, cyclic lipopeptides like daptomycin insert into bacterial membranes to cause ion leakage, while polyene antibiotics like amphotericin B bind to ergosterol to create lethal pores in fungal cells (Humphries et al., 2013, Clinical Infectious Diseases). Furthermore, lipid intermediates like Lipid II are critical 'bottleneck' molecules in cell wall assembly, making them highly sensitive targets for newer antibiotics like teixobactin (Schneider & Sahl, 2010, Nature Reviews Microbiology). Because many of these lipid structures are unique to microbes, they offer a degree of selectivity, although toxicity remains a concern due to the fundamental similarities between all biological membranes.
Drugs targeting these components act through several mechanisms: direct physical disruption of the lipid bilayer leading to pore formation and leakage of intracellular contents (e.g., polymyxins, polyenes); calcium-dependent insertion into the membrane causing rapid depolarization (e.g., daptomycin); binding to lipid-linked precursors like Lipid II to halt peptidoglycan synthesis (e.g., glycopeptides); or inhibiting the biosynthesis of essential envelope lipids such as mycolic acids (e.g., isoniazid) (Schneider & Sahl, 2010, Nature Reviews Microbiology; Mesa-Arango et al., 2012, Frontiers in Microbiology).
10 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell membrane and cell wall envelope lipids.